PROTAC Bromodomain Inhibitor ARV-825 Displays Anti-Tumor Activity in Neuroblastoma by Repressing Expression of MYCN or c-Myc

Overview of attention for article published in Frontiers in oncology, November 2020

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 1 X post from an account with 3,929 followers.

PROTAC Bromodomain Inhibitor ARV-825 Displays Anti-Tumor Activity in Neuroblastoma by Repressing Expression of MYCN or c-Myc https://t.co/ccMh8oKpBc

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.